GSK under pressure to acquire other firms to build pipeline

GlaxoSmithKline is under strong pressure from institutional investors to use its billions in cash reserves rather than saving them. Investors are clamoring for GSK to acquire other companies as part of a broader effort to improve its drug pipeline.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA
Senior Compliance Analyst
ACell, Inc.
Columbia, MD